Caliber Imaging & Diagnostics, Inc. Stock

Equities

LCDX

US13001C1053

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 09:38:57 2024-04-19 am EDT 5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Caliber Imaging & Diagnostics, Inc. 0.00% 0.00%
Sales 2012 2.43M Sales 2013 3.34M Capitalization 4.61M
Net income 2012 -9M Net income 2013 -5M EV / Sales 2012 7.45 x
Net Debt 2012 6.15M Net Debt 2013 10.99M EV / Sales 2013 4.67 x
P/E ratio 2012
-1.22 x
P/E ratio 2013
-0.84 x
Employees 28
Yield 2012 *
-
Yield 2013
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
VivaScope GmbH signed a definitive agreement to acquire Caliber Imaging & Diagnostics, Inc.. CI
Saudi PIF nearly triples U.S. stock holdings; adds Walmart, Pinterest RE
Caliber Imaging & Diagnostics, Inc. announced that it has received $2.786032 million in funding CI
Caliber Imaging & Diagnostics, Inc. Secures $5.0 Million in Debt Financing from Bridge Bank CI
Caliber Imaging & Diagnostics, Inc. announced a financing transaction CI
Caliber Imaging & Diagnostics, Inc. Names Karen Howe as Chief Financial Officer CI
Caliber Imaging & Diagnostics, Inc. Hires Lisa Edone as Regional Sales Manager for Its VIVASCOPE Skin Imaging Division CI
Caliber Imaging & Diagnostics, Inc. Releases its Latest VIVASCOPE 1500 Confocal Imaging System for Capturing Digital Images of Skin At the Cellular-Level CI
Doug Leahy Joins Caliber Imaging & Diagnostics, Inc. as Vice President of Reimbursement and Health Economics CI
Caliber Imaging & Diagnostics, Inc. Announces FDA 510(k) Clearance for its VIVASCOPE System CI
Caliber Imaging & Diagnostics, Inc. cancelled the transaction announced on October 25, 2013. CI
Caliber Imaging & Diagnostics, Inc. that it has received $16.10 million in funding. CI
Caliber Imaging & Diagnostics, Inc. announced that it has received $0.9 million in funding from Osiris Capital Management and other investors. CI
Caliber Imaging & Diagnostics, Inc. announced that it has received $0.20 million in funding. CI
Caliber Imaging & Diagnostics Appoints William F. O'dell to its Board of Directors CI
More news
1 week
0.00
Extreme 0.0001
0.00
1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0.0001
0.00
1 year
0.00
Extreme 0.0001
0.05
3 years
0.00
Extreme 0.0001
0.57
5 years
0.00
Extreme 0.0001
6.40
10 years
0.00
Extreme 0.0001
6.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 74 01-12-31
Chief Tech/Sci/R&D Officer 58 98-12-31
Sales & Marketing - 11-10-31
Members of the board TitleAgeSince
Chairman 76 98-02-28
Director/Board Member 77 14-05-07
Chief Executive Officer 74 01-12-31
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 19, 2024 at 09:38 am EDT

More quotes
Caliber Imaging & Diagnostics, Inc. is a medical technology company. The Company designs, develops, and markets imaging solutions that show tissue at the cellular level. It offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Its Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye. It has developed the VivaScope, a suite of imaging products. Its telepathology system allows near real-time collaboration with remote specialists. Its clinical products include VivaScope 1500, VivaScope 2500, VivaScope 3000 and VivaNet & VivaScan. Its research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 reflectance confocal imaging system offers a non-invasive way to image the skin in vivo from the surface to the superficial collagen layers.
More about the company